QuinXell Technologies Pte Ltd was founded in 2011 as a member of Quintech Life Sciences. QuinXell’s core expertise lies in the emerging field of Regenerative Medicine, through the company’s innovative cell culture technologies.

Their product, The TisXell Regeneration System, has its origins as a joint collaboration between the National University of Singapore (NUS) and the Singapore Polytechnic (SP). The introduction of TisXell is the outcome of intensive research and engineering, illustrated by published articles in international journals.